{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:03Z","timestamp":1787772123450,"version":"build-2784847793"},"reference-count":49,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015756","name":"Janssen-Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Psychiatry in Clinical Practice"],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.1080\/13651501.2022.2030757","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T12:32:15Z","timestamp":1645101135000},"page":"352-362","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":50,"title":["Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme"],"prefix":"10.1080","volume":"26","author":[{"given":"Ludovic","family":"Samalin","sequence":"first","affiliation":[{"name":"Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal (UMR 6602), Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Roth\u00e4rmel","sequence":"additional","affiliation":[{"name":"University Department of Psychiatry, Therapeutic Centre of Excellence, Institute of Psychiatry \u2013 Rouvray Hospital Centre, Sotteville-l\u00e8s-Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Mekaoui","sequence":"additional","affiliation":[{"name":"Mental and Brain Illness Clinic, Sainte-Anne Hospital, GHU Paris \u2013 Psychiatry and Neurosciences, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Gaudr\u00e9-Wattinne","sequence":"additional","affiliation":[{"name":"Medical Affairs, Janssen-Cilag, Issy-les-Moulineaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Alix","family":"Codet","sequence":"additional","affiliation":[{"name":"Medical Affairs, Janssen-Cilag, Issy-les-Moulineaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bouju","sequence":"additional","affiliation":[{"name":"Medical Affairs, Janssen-Cilag, Issy-les-Moulineaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sauvaget","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"CIT0001","unstructured":"American Psychological Association. 2019. Clinical practice guideline for the treatment of depression across three age cohorts. [accessed 2021 March 10]. https:\/\/www.apa.org\/depression-guideline\/guideline.pdf"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2237-x"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5082"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2019.07.003"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0013-7006(17)30155-0"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.1189"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2015.04.015"},{"key":"CIT0008","unstructured":"European Medicines Agency. 2017. SPRAVATO 28\u2009mg, solution pour pulv\u00e9risation nasale. R\u00e9sum\u00e9 des caract\u00e9ristiques produit.: 1\u2013150. [accessed June 23, 2021]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/spravato-epar-product-information_fr.pdf"},{"key":"CIT0009","unstructured":"European Medicines Agency. 2021. Spravato 28\u2009mg nasal spray (esketamine), solution. Summary of Product Characteristics. [accessed 2021 June 23]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/spravato-epar-product-information_en.pdf"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-9-26"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(03)00231-2"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz039"},{"key":"CIT0013","unstructured":"French National Agency for Medicines and Health Products (ANSM). 2015. Notice to applicants for marketing for Temporary Authorisation for Use. [accessed 2021 June 23]. https:\/\/archiveansm.integra.fr\/content\/download\/79919\/1011615\/version\/1\/file\/Notice-aaplicants-marketing_ATU.pdf"},{"key":"CIT0014","unstructured":"French National Agency for Medicines and Health Products (ANSM). 2020. Annual Report 2019. [accessed 2021 June 23]. https:\/\/ansm.sante.fr\/uploads\/2021\/01\/19\/20201104-annual-report-2019-1.pdf"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.11.124"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.3.618"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13400"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719001612"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2222-4"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.06.045"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyy094"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1177\/070674371405901206"},{"key":"CIT0023","first-page":"637","volume":"32","author":"L\u00e9on C","year":"2018","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00767"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.03.039"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2165\/11633130-000000000-00000"},{"key":"CIT0028","unstructured":"National Institute of Health and Care Excellence. 2020. Esketamine for treating treatment-resistant depression (Appraisal consultation document TA10371). [accessed 2020 December 19]. https:\/\/www.nice.org.uk\/guidance\/gid-ta10371\/documents\/129"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.11.038"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2019.10.008"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852918001207"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19020172"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.06.030"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.02.020"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(03)00088-X"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1177\/2042098620937899"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000513"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000806"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.148.5.599"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(98)00004-2"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"issue":"13","key":"CIT0043","first-page":"23","volume":"58","author":"Thase ME","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00450"},{"key":"CIT0045","unstructured":"U.S. Food and Drug Administration. 2020. SPRAVATO\u00ae (esketamine) nasal spray, CIII. Prescribing Information. [accessed 2021 June 23]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211243lbl.pdf"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12891"},{"key":"CIT0047","unstructured":"World Health Organization. 2017. Depression and other common mental disorders: global health estimates. (accessed 2022 January 21) https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/254610\/WHO-MSD-MER-2017.2-eng.pdf"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10120962"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856"}],"container-title":["International Journal of Psychiatry in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13651501.2022.2030757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:37:50Z","timestamp":1670272670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13651501.2022.2030757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11,1]]}},"alternative-id":["10.1080\/13651501.2022.2030757"],"URL":"https:\/\/doi.org\/10.1080\/13651501.2022.2030757","relation":{},"ISSN":["1365-1501","1471-1788"],"issn-type":[{"value":"1365-1501","type":"print"},{"value":"1471-1788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijpc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijpc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}